IL6 and esophageal squamous cell carcinoma: In line with the above CFA results in Fig. 5Q, R, deletion of KDM1A in RAD51 deficient ESCC cells did not result in obvious increases of IL-6 and IL-1B in TE1 (Fig. 6B, p = 0.0001 and p = 0.0073 for IL-6, p = 0.0006 and p < 0.0001 for IL-1B, respectively) and K410 (Fig. 6C, p = 0.0001 and p < 0.0001 for IL-6, p = 0.006 and p < 0.0001 for IL-1B, respectively).